Effect | None |
Trial Design | Double blind |
Trial Length | n/a |
Number of Subjects | 46 |
Sex | n/a |
800mg SAMe daily (in two doses of 400mg) for two weeks, followed by six weeks of a double dose (four doses of 400mg) in subjects with SSRI therapy was associated with improved recall and a trend to improved cognitive performance without influencing parameters of wakefulness or focus